To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

MAIL-ORDER PHARMACY

TODAY'S HEADLINES

Mail order boosts med adherence for stroke patients

Stroke patients were more adherent to mail-order prescriptions versus picking up their medications at retail pharmacies, according to a new study. Read more

FDA approves first once-daily RA drug

FDA has approved tofacitinib citrate extended-release (Xeljanz XR, Pfizer) tablets for the treatment of moderate to severe rheumatoid arthritis. Read more

CONTINUING PHARMACY EDUCATION

Part 1: Recognition and referral to enhance recovery: The pharmacist's role in managing opioid use disorder

This month's CE activity is open for pharmacists and pharmacy technicians, "Part 1: Recognition and referral to enhance recovery: The pharmacist's role in managing opioid use disorder." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Another win for biosimilar arthritis drugs

FDA gets behind a biosimilar to Remicade. Details

March 4, 2016

Related Articles

First-line stroke medication may be given by paramedics

Sarilumab effective in broad range of RA patients

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us